case_images: PMC6404238_01
case_images: Chest radiograph reveals the Impella 2.5 device positioned into the left
  ventricle.
case_images: 10.1177_2050313X19834816-fig1.jpg
case_images: PMC6404238_01_10.1177_2050313X19834816-fig1.jpg
case_images: fig1-2050313X19834816
case_images: Due to severe cardiogenic shock, an Impella 2.5 device (ABIOMED Inc., Danvers, MA, USA) was deployed through the femoral artery (Figure 1).
case_images: Chest radiograph reveals the central cannulation for the VA ECMO support.
case_images: 10.1177_2050313X19834816-fig2.jpg
case_images: PMC6404238_01_10.1177_2050313X19834816-fig2.jpg
case_images: fig2-2050313X19834816
case_images: ECMO support was established via central cannulation and left ventricle (LV) vent was placed through the right superior pulmonary vein and connected to the inflow cannula in a Y-shaped fashion to unload the LV. ECMO support was continued for 15 days during which the circuit was changed once due to thrombus formation in the circuit (Figure 2).
case_images: Chest radiograph reveals the HVAD implanted into the apex of the left
  ventricle.
case_images: 10.1177_2050313X19834816-fig3.jpg
case_images: PMC6404238_01_10.1177_2050313X19834816-fig3.jpg
case_images: fig3-2050313X19834816
case_images: After 15 days of ECMO support, a HVAD (Medtronic, Minneapolis, MN, USA) was implanted and ECMO was discontinued (Figure 3).